Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | FYN | P06241 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31554010 | 1.00 | CA2 (0.39) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL17236446 | 0.91 | CA2 (0.37) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL3197464 | 0.79 | TRPA1 (0.43) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL26146898 | 0.78 | ALDH1A1 (0.39) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL3220980 | 0.78 | HPGD (0.33) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL3187595 | 0.75 | CA12 (0.40) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL18124824 | 0.73 | CA1 (0.39) | CA2CA1CA12CA9ORAI1 | |
| SCHEMBL6693267 | 0.73 | ACHE (0.39) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL3179138 | 0.73 | CYP3A4 (0.39) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL28007709 | 0.73 | CA1 (0.35) | CA2CA1CA12CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214507-A1 | BORONIC ACID MONOMERS AND METHODS OF MAKING BORONIC ACID MONOMERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-07-15 | — | — | US | disclosed |
| US-11001675-B2 | Boronic acid monomers and methods of making boronic acid monomers | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2021-05-11 | — | — | US | disclosed |
| US-20200071466-A1 | BORONIC ACID MONOMERS AND METHODS OF MAKING BORONIC ACID MONOMERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2020-03-05 | — | — | US | disclosed |
| WO-2008059259-A2 | ANTICANCER COMPOUNDS WITH A BENZO ( 1, 2, 4 ) TRIAZIN-3YL-AMINE CORE | SENTINEL ONCOLOGY LIMITED (GB) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214507-A1 | BORONIC ACID MONOMERS AND METHODS OF MAKING BORONIC ACID MONOMERS | MMAB, ME1, BPGM | CA2 227/4885CA1 455/4885CA12 428/4885 |
| US-11001675-B2 | Boronic acid monomers and methods of making boronic acid monomers | MMAB, ME1, BPGM | CA2 227/4885CA1 455/4885CA12 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.